Table 3.
Distribution of Morbidity by Site
| Morbidity | Oral Cavity (n=20) | Larynx (n=6) |
|---|---|---|
| Pain, No. | ||
| Mild | 15 | 1 |
| Moderate | 2 | 1 |
| Severe | 0 | 0 |
| Edema, No. | ||
| Mild | 14 | 0 |
| Moderate | 1 | 0 |
| Severe | 2 | 0 |
| Phototoxicity, No. | ||
| Mild | 7 | 3 |
| Moderate | 3 | 1 |
| Severe | 1 | 0 |
| Itching, No. | 2 | 0 |
| Weight loss, No. | 1 | 0 |
| Transient hoarseness, No.a | NA | 6 |
Abbreviation: NA, not applicable.
a
The hoarseness in laryngeal patients was transient. On follow-up, all the patients had significant improvement in voice quality compared with the pretreatment status.